Engineering strategies of sequential drug delivery systems for combination tumor immunotherapy
Over the past few decades, tumor immunotherapy has revolutionized the landscape of cancer clinical treatment. There is a flourishing development of combination strategies to improve the anti-tumor efficacy of mono-immunotherapy. However, instead of a straightforward combination of multiple therapeut...
Saved in:
| Main Authors: | Zhenyu Xu, Siyan Liu, Yanan Li, Yanping Wu, Jiasheng Tu, Qian Chen, Chunmeng Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525003776 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovations in Cancer Immunotherapy Drug Delivery Technologies: A Systematic Review
by: Kavita Sharma, et al.
Published: (2025-05-01) -
Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study
by: Zhou Meng-Xi, et al.
Published: (2025-01-01) -
On‐Demand Controlled Release Multi‐Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy
by: Chenglin Liang, et al.
Published: (2025-03-01) -
Recent Advances in mRNA Delivery Systems for Cancer Therapy
by: Zheng Zhang, et al.
Published: (2025-08-01) -
Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade
by: Ting Zhang, et al.
Published: (2025-06-01)